Morbidity and Mortality: Surgery and Standardized Transmission in Operating Room
ConditionMajor Surgery
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAssistance Publique - Hôpitaux de Paris
About this trial
The primary objective of the study is to evaluate the efficacy of standard handover with AnesList© between physician anesthesists in operating room, for a complete transmission for a patient, on the occurence of event as death, serious complications or rehospitalization in month of postoperative after major surgery.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patient aged > 18 years;
Patients with score ASA I-IV;
Requiring urgent or planned surgery;
Major surgery (duration of surgery > 2 hours, requiring a hospital stay of at least 1 night): orthopedics, cardiac, vascular, thoracic, visceral, ENT, plastic surgery;
Disqualifiers
Transmission between physician anaesthesist and nurse anaesthetist;
Medical transmission occurs out of anesthesia care out of operating room;
Medical transmission occurs in transitory manner (for example: coffee time, lunch time);
Patients enrolled in an another ongoing study of surgical intervention.
Trial population
Adult patients requiring urgent or planned major surgery (duration of surgery \> 2 hours, requiring a hospital stay of at least 1 night): orthopedics, cardiac, vascular, thoracic, visceral, ENT, plastic surgery; with handover between two anesthesists defined as a definitive relay between one physician anaesthesist and another in operating room; Intensive care anesthesists and nurse anaesthetist working in investigator center during the study.
Trial design
Design model
Case-control
Time perspective
Prospective
Treatments tested in this trial
Training with AnesList©
Other interventionTraining with AnesList© as tool
Treatment groups
1,120 Participants
are divided into 3 treatment groupsGroup A: Experimental group1 intervention
Group B: Control group with delayed training1 intervention
Group C: Control group without training0 interventions
Trial outcomes
Primary outcomes
1
The occurence of adverse events
Death, serious complications and re-hospitalization will be noted in order to evaluate the efficacy of standardized transmission with AnesList©.
Time frame
at 1 monthSecondary outcomes
1
The duration of ICU stay
The length of initial ICU stay will be noted.
Time frame
through study completion, an average of 18 months2
The duration of hospitalization
The length of initial hospitalization will be noted.
Time frame
through study completion, an average of 18 months3
Evaluate of the condition of transmission
By the presence or intervention of anaesthetics-nurse, recorded or not the transmission in medical files.
Time frame
through study completion, an average of 18 months4
Utilization of the AnesList© by anaesthesists at 6 months
Only for intervention group: use on cell phone or with printed form: the use will be noted.
Time frame
at 6 monthsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov